Abstract:Modulating hierarchical architectures produces ultrasmall Fe2O3 nanocrystal assembles conjugated with cancer cell targeting folic acid and chemotherapeutic drug doxorubicin. Dependent on the assembled Fe2O3 nanocrystals, these architectures show dynamically switchable magnetic resonance imaging, and highly efficient photothermal‐ferroptotic‐chemical synergistic cancer therapy for tumor ablation. RNA sequencing analyses suggest ferroptosis is fundamental during synergistic therapy, despite excellent second near‐infrared photothermal conversion. Ferroptosis is recently discovered programmed cell death, induced by cellular ferrous ion bursts and subsequent Fenton reactions. The iron source in tumor cells is limited due to tightly controlled iron metabolism. Since hierarchical iron architecture is rarely considered in ferroptosis cancer treatment, multilayer Fe2O3 architectures (UF@PPDF NPs) are developed by modulating ultra‐small γ‐Fe2O3 nanocrystal assemblies, and further conjugating cancer cell targeting folic acid (FA), chemotherapeutic drug doxorubicin (Dox). Hierarchically assembled γ‐Fe2O3 nanocrystal facilitates switchable magnetic resonance imaging (MRI), much enhanced ferroptosis efficiency, and very high second near‐infrared (NIR‐II) photothermal conversion. For MRI, UF@PPDF nanoparticles (NPs) enables clearly visualized tissues in terms of size and compactness, with dynamic T2‐T1 imaging switching. UF@PPDF NPs exhibits highly efficient photothermal therapy (PTT) upon NIR‐II irradiation, together with controlled release of ferric ions and Dox, thus achieving PTT‐chemotherapy‐ferroptosis trifunctional synergistic cancer therapy for tumor ablation. RNA sequencing analyses of differentially expressed genes implies a multifaceted role for this therapy in cancer cell signaling. Cellular respiration and electron transport are significantly upregulated, while the epigenetic pathways, including chromatin modification and RNA transcription activity are severely downregulated, with an overall effect of cellular apoptosis. Thus, γ‐Fe2O3 architectures provide new possibility for highly efficient deep tumor treatment.

Dual key co-activated nanoplatform for switchable MRI monitoring accurate ferroptosis-based synergistic therapy

Efficient Magnetic Nanocatalyst-Induced Chemo- and Ferroptosis Synergistic Cancer Therapy in Combination with T 1 –T 2 Dual-Mode Magnetic Resonance Imaging Through Doxorubicin Delivery

A tumor microenvironment responsive nanoplatform with oxidative stress amplification for effective MRI-based visual tumor ferroptosis

Nanoplatforms with synergistic redox cycles and rich defects for activatable image-guided tumor-specific therapy

A redox homeostasis disruptor based on a biodegradable nanoplatform for ultrasound (US) imaging-guided high-performance ferroptosis therapy of tumors

Activatable Biomineralized Nanoplatform Remodels the Intracellular Environment of Multidrug‐Resistant Tumors for Enhanced Ferroptosis/Apoptosis Therapy

Dual-targeting nanotheranostics for MRI-guided enhanced chemodynamic therapy of hepatoma via regulating the tumor microenvironment

Multifunctional nanoplatform for photoacoustic imaging-guided combined therapy enhanced by CO induced ferroptosis.

Exogenously Triggered Nanozyme for Real-Time Magnetic Resonance Imaging-Guided Synergistic Cascade Tumor Therapy.

Fe 3+ -DOX-Mediated Self-Assembled Nanolipids for Tumor Microenvironment Activated Synergistic Ferroptotic-Chemo Therapy Assisted with MR-imaging

Modulated Ultrasmall γ‐Fe2O3 Nanocrystal Assemblies for Switchable Magnetic Resonance Imaging and Photothermal‐Ferroptotic‐Chemical Synergistic Cancer Therapy

Enhanced Real‐Time Monitoring of Catalytic Therapy Efficacy with Dual‐Channel MRI and Fluorescent Platform

A novel intratumoral pH/redox-dual-responsive nanoplatform for cancer MR imaging and therapy

Nanovesicle-templated Nanogel: A Dual-Modal Platform Integrating Intracellular Iron Homeostasis Disruption for Ferroptosis and MRI-guided Tumor Diagnosis

Protease‐Activatable Nanozyme with Photoacoustic and Tumor‐Enhanced Magnetic Resonance Imaging for Photothermal Ferroptosis Cancer Therapy

Fe-Mediated Self-Assembled Nanodrug for Tumor Microenvironment Activated Synergistic Ferroptosis-Based-Chemodynamic/Chemo Therapy and Magnetic Resonance Imaging

A Biomimetic Nanodrug Self-Assembled from Small Molecules for Enhanced Ferroptosis Therapy

Ferroptosis/pyroptosis dual-inductive combinational anti-cancer therapy achieved by transferrin decorated nanoMOF

Self-amplification of Oxidative Stress with Tumour Microenvironment-Activatable Iron-Doped Nanoplatform for Targeting Hepatocellular Carcinoma Synergistic Cascade Therapy and Diagnosis

A Strategy of Fenton Reaction Cycloacceleration for High-Performance Ferroptosis Therapy Initiated by Tumor Microenvironment Remodeling

Redox-Sensitive Clustered Ultrasmall Iron Oxide Nanoparticles for Switchable T2/T1-Weighted Magnetic Resonance Imaging Applications